Method to reduce hepatotoxicity of fas-mediated...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2566975

The invention concerns a method to prevent or reduce adverse effects on liver of a patient treated with a Fas-mediated apoptosis-inducing agent, the method comprising the administration of a product preventing TNF receptors-mediated apoptosis of the liver cells.

Cette invention concerne un procédé visant à prévenir ou à réduire les effets indésirables causés sur le foie d'un patient traité avec un agent inducteur d'apoptose induite par Fas, lequel procédé consiste à administrer un produit ayant pour effet de prévenir l'apoptose induite par les récepteurs TNF des cellules hépatiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method to reduce hepatotoxicity of fas-mediated... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method to reduce hepatotoxicity of fas-mediated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to reduce hepatotoxicity of fas-mediated... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1735805

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.